ImmuPharma

United Kingdom
City of Westminster, England, United Kingdom
+44 20 7206 2650 ★

Company profile

ImmuPharma company profile

ImmuPharma focuses in developing pioneering and novel drugs in specialist therapeutic areas where there is a distinct lack of existing treatments, avoiding primary care (diseases treated by GPs) where many treatments exist. This is consistent with the trends in the pharmaceutical industry. Since our foundation, our research strategy has been to work closely with the largest fundamental research organisation in Europe, the Centre National de la Recherche Scientifique, (CNRS) in France. This collaboration enables us to access innovative research with substantial embedded value at a relatively low cost, and to work with many leading scientists and doctors. ImmuPharma has exclusive..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Phone number
+44 20 7206 2650
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
1999-01-01

Headquarters

Headquarters
City of Westminster, England, United Kingdom
Postal code
SW1H 0RG
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
2
Total equity funding
$12.6M
Last funding
Post Ipo Equity / $12.1M / 2016-02-10
Last equity funding
Post Ipo Equity / $12.1M
Investors
1
Founders
2
Articles
31
Exited on
2006-02-17

Founders and investors

Founders

Gilles GuichardJean-Paul Briand

Investors

Lanstead Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.